ES2059328T3 - Agentes para el tratamiento de artrosis. - Google Patents

Agentes para el tratamiento de artrosis.

Info

Publication number
ES2059328T3
ES2059328T3 ES87110603T ES87110603T ES2059328T3 ES 2059328 T3 ES2059328 T3 ES 2059328T3 ES 87110603 T ES87110603 T ES 87110603T ES 87110603 T ES87110603 T ES 87110603T ES 2059328 T3 ES2059328 T3 ES 2059328T3
Authority
ES
Spain
Prior art keywords
agents
treatment
arthroses
arthrosis
cold water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87110603T
Other languages
English (en)
Inventor
Peter Dr Koepff
Alexander Muller
Reinhard Schrieber
Angelika Dr Turowski
Klaus Dr Braumer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stoess & Co Gelatine
Gelita AG
Original Assignee
Stoess & Co Gelatine
Deutsche Gelatine Fabriken Stoess and Co GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stoess & Co Gelatine, Deutsche Gelatine Fabriken Stoess and Co GmbH filed Critical Stoess & Co Gelatine
Application granted granted Critical
Publication of ES2059328T3 publication Critical patent/ES2059328T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)

Abstract

MEDIO PARA TRATAMIENTO DE ARTROSIS QUE COMPRENDE PEPTIDOS DE DISOLUCION ACUOSA FRIA, ESPECIALMENTE DEL GRUPO DEL COLAGENO HIDROLIZADO. LOS PEPTIDOS DE DISOLUCION ACUOSA FRIA SE UTILIZAN PARA EL TRATAMIENTO DE ARTROSIS O PARA LA FABRICACION DE MEDIOS PARA TRATAMIENTO DE ARTROSIS.
ES87110603T 1986-07-25 1987-07-22 Agentes para el tratamiento de artrosis. Expired - Lifetime ES2059328T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3625185 1986-07-25

Publications (1)

Publication Number Publication Date
ES2059328T3 true ES2059328T3 (es) 1994-11-16

Family

ID=6305969

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87110603T Expired - Lifetime ES2059328T3 (es) 1986-07-25 1987-07-22 Agentes para el tratamiento de artrosis.

Country Status (8)

Country Link
US (1) US4804745A (es)
EP (1) EP0254289B1 (es)
JP (1) JPH0696539B2 (es)
AT (1) ATE96033T1 (es)
AU (1) AU594488B2 (es)
CA (1) CA1302880C (es)
DE (1) DE3787842D1 (es)
ES (1) ES2059328T3 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040115217A1 (en) * 1987-06-24 2004-06-17 Autolmmune Inc. Bystander suppression of autoimmune diseases
US5849298A (en) * 1987-06-24 1998-12-15 Autoimmune Inc. Treatment of multiple sclerosis by oral administration of bovine myelin
US5869054A (en) * 1987-06-24 1999-02-09 Autoimmune Inc. Treatment of multiple sclerosis by oral administration of autoantigens
US6645504B1 (en) 1987-06-24 2003-11-11 Autoimmune Inc. Bystander suppression of type I diabetes by oral administration of glucagon
US5843445A (en) * 1987-06-24 1998-12-01 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
IL99754A (en) * 1990-10-15 1996-08-04 Autoimmune Inc Pharmaceutical preparation containing autoantib or particle or analogue for the treatment of autoimmune arthritis and multiple sclerosis
DE4125400C2 (de) * 1991-07-31 2000-08-17 Edwin Klaus Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen
HU220357B (hu) * 1992-02-28 2001-12-28 Autoimmune Inc. Eljárás és készítmények autoimmun betegségek kezelésére bystander antigén alkalmazásával
US5591719A (en) * 1992-12-10 1997-01-07 Regents Of The University Of Minnesota Method for treating acute and chronic inflammatory disorders using polypeptides with fibronectin activity
DK0609471T3 (da) * 1993-02-02 2000-05-29 Edwin Dr Klaus Anvendelse af kollagen til behandling af sygelige ledprocesser
FR2720067B1 (fr) * 1994-05-17 1996-08-02 Dielen Lab Hydrolysat de protéines d'animaux marins, procédé d'obtention et applications.
PT777491E (pt) * 1994-08-23 2005-01-31 Stoess & Co Gelatine Utilizacao de colagenio hidrolisado, de sabor neutro e agente que o contem
US6334219B1 (en) * 1994-09-26 2001-12-25 Adc Telecommunications Inc. Channel selection for a hybrid fiber coax network
US5856446A (en) * 1995-07-07 1999-01-05 Autoimmune Inc. Method of treating rheumatoid arthritis with low dose type II collagen
JP4609807B2 (ja) 1996-03-28 2011-01-12 雪印乳業株式会社 骨強化用医薬、飲食品及び飼料
JP2001524080A (ja) * 1997-04-10 2001-11-27 レクサル サンダウン 関節炎の治療用加水分解コラーゲンタンパク質およびグルコサミンを含む組成物
US5849336A (en) 1997-07-02 1998-12-15 Abbott Laboratories Method using sturgeon notochord for alleviating the symptoms of arthritis
US6025327A (en) 1997-08-08 2000-02-15 Biocell Technology, Llc Hydrolyzed collagen type II and use thereof
US6136341A (en) * 1998-02-27 2000-10-24 Petito; George D. Collagen containing tissue adhesive
US6224871B1 (en) 1998-03-11 2001-05-01 Reliv International, Inc. Dietary supplement for nutritionally promoting healthy joint function
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
WO1999048516A1 (es) * 1998-03-25 1999-09-30 Masterfarm, S.L. Uso de hidrolizados de gelatina
US6162787A (en) * 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
US6333304B1 (en) 1999-04-20 2001-12-25 Teresa K. Bath Therapeutic compositions containing glucosamine, collagen and a bioflavanol for repair and maintenance of connective tissue
US6721142B1 (en) * 2000-12-21 2004-04-13 Western Digital (Fremont) Inc. Non-corrosive GMR slider for proximity recording
US6838440B2 (en) * 2001-01-24 2005-01-04 Collagen Nutraceuticals, Inc. Kolla2-desiccated avian sternal cartilage powder
US7119062B1 (en) 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US6780841B2 (en) 2001-11-13 2004-08-24 Biocell Technology, Llc Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
NZ534760A (en) 2002-01-23 2006-03-31 Inst Of Nutraceutical Res Pty Nutraceuticals for the treatment, protection and restoration of connective tissues
US20040029774A1 (en) * 2002-08-06 2004-02-12 Aly Gamay Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies
US8377904B2 (en) * 2004-02-09 2013-02-19 Hill's Pet Nutrition, Inc. Composition and method for use in cartilage affecting conditions
CN101022823A (zh) * 2004-07-28 2007-08-22 卡吉尔公司 基于胶原蛋白的生理活性组合物
JP4033877B2 (ja) 2005-09-29 2008-01-16 株式会社ファンケル Ｉ型コラーゲン産生促進用組成物
WO2007044945A2 (en) * 2005-10-13 2007-04-19 Gu, Jennifer, L. Mineral collagen chelates and methods of making and using same
EP2032170B1 (en) * 2006-06-14 2012-11-28 N.V. Nutricia Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
US8703174B2 (en) * 2006-09-15 2014-04-22 I Did It Inc Joint preserving nutritional vitamin, mineral and herbal pet supplement
US9549959B2 (en) * 2006-09-15 2017-01-24 I Did It, Inc. Animal chew toy containing solid food
DE102007063429A1 (de) * 2007-12-19 2009-06-25 Animox Gmbh Reaktives Additiv aus eiweißhaltigen Rohstoffen und Abprodukten tierischer oder pflanzlicher Herkunft
DE102009030351A1 (de) 2009-06-22 2010-12-23 Gelita Ag Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
CN105431159B (zh) * 2013-05-14 2020-12-01 马斯公司 关节护理组合物
EP3595695A1 (en) * 2017-03-15 2020-01-22 Rousselot B.V. Compositions of hydrolyzed collagen peptides and commensal microorganisms and methods thereof
WO2018209008A1 (en) 2017-05-11 2018-11-15 Avicenna Nutracetical, Llc Methods for producing collagen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1227534A (es) * 1967-08-31 1971-04-07
DE2462222A1 (de) * 1974-02-02 1976-05-06 Trommsdorff Fa H Loesliches, natives human-kollagen, dessen nicht-helikale peptide teilweise oder vollstaendig abgetrennt sind

Also Published As

Publication number Publication date
CA1302880C (en) 1992-06-09
AU7609687A (en) 1988-01-28
ATE96033T1 (de) 1993-11-15
AU594488B2 (en) 1990-03-08
US4804745A (en) 1989-02-14
JPH0696539B2 (ja) 1994-11-30
DE3787842D1 (de) 1993-11-25
EP0254289A3 (en) 1989-10-18
JPS6339821A (ja) 1988-02-20
EP0254289A2 (de) 1988-01-27
EP0254289B1 (de) 1993-10-20

Similar Documents

Publication Publication Date Title
ES2059328T3 (es) Agentes para el tratamiento de artrosis.
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
DE69019488D1 (de) Behandlung von Geflügel.
NO873699D0 (no) Polypeptid som er egnet til dempning, behandling og diagnosering av autoimmune lidelser saasom leddbetennelser.
DE3775371D1 (de) Schenkelhalsprothese.
DE69018043D1 (de) Behandlung von Geflügel.
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
FR2491334B1 (es)
FI833116A7 (fi) Farmaseuttisia valmisteita haitallisten yhteenkasvamien käsittelemiseksi sekä niiden käyttö.
DE3781652D1 (de) Zubereitung, geeignet fuer die behandlung von darmstoerungen.
ES548052A0 (es) Procedimiento para preparar peptidos
DE3764053D1 (de) Behandlung von waesserigem abfall.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
AR240482A1 (es) Procedimiento para el curtimiento economico al cromo.
ZA855224B (en) Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
DE3769910D1 (de) Verwendung von n, n'-bis-l-aminosaeure-l-cystinpeptiden in aminosaeure-praeparaten fuer orale und parenterale ernaehrung.
ES536142A0 (es) Instalacion para le tratamiento mecanico de los bajos buque en el dique.
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
ES2180562T3 (es) Procedimiento de tratamiento de la madera para utilizar en la aromatizacion de productos alimenticios acuosos.
ES517596A0 (es) Procedimiento para la preparacion de un peptido.
DE3885798D1 (de) Proteinhaltiges Polysaccharid zur Behandlung retroviraler Infektionen.
IT8722543V0 (it) Cerotto, in particolare per l'impiego in corrispondenza di zone articolari.
DE3787493D1 (de) Lederbehandlungsmittel.
MX17601A (es) Composicion para el tratamiento de leishmaniasis yprocedimiento para su preparacion .
IT8285511A0 (it) Procedimento per l'estrazione e purificazione delle proteine, sotto forma di polipeptidi solubili, dagli scarti di conceria.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 254289

Country of ref document: ES